BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 9196022)

  • 21. Adenomatous polyposis coli gene as a gatekeeper.
    Nakayama T; Morishita T; Kamiya T
    Rev Gastroenterol Peru; 2002; 22(2):164-7. PubMed ID: 12098745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
    Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
    Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the APC tumor suppressor protein with catenins.
    Su LK; Vogelstein B; Kinzler KW
    Science; 1993 Dec; 262(5140):1734-7. PubMed ID: 8259519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of kinesin expression disrupts adenomatous polyposis coli (APC) localization and affects beta-catenin turnover in young adult mouse colon (YAMC) epithelial cells.
    Cui H; Dong M; Sadhu DN; Rosenberg DW
    Exp Cell Res; 2002 Oct; 280(1):12-23. PubMed ID: 12372335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current data on the role of APC protein in the origin of colorectal cancer].
    Bonneton C; Larue L; Thiery JP
    Bull Cancer; 1997 Nov; 84(11):1053-60. PubMed ID: 9536987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinogenesis: a balance between beta-catenin and APC.
    Gumbiner BM
    Curr Biol; 1997 Jul; 7(7):R443-6. PubMed ID: 9210368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The colorectal tumor suppressor APC and its partners.
    Samarut J
    Jpn J Cancer Res; 1997 Aug; 88(8):inside front cover. PubMed ID: 9330598
    [No Abstract]   [Full Text] [Related]  

  • 29. APC truncation and increased beta-catenin levels in a human breast cancer cell line.
    Schlosshauer PW; Brown SA; Eisinger K; Yan Q; Guglielminetti ER; Parsons R; Ellenson LH; Kitajewski J
    Carcinogenesis; 2000 Jul; 21(7):1453-6. PubMed ID: 10874025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.
    Sieber OM; Tomlinson IP; Lamlum H
    Mol Med Today; 2000 Dec; 6(12):462-9. PubMed ID: 11099951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the APC gene product with beta-catenin.
    Rubinfeld B; Souza B; Albert I; Müller O; Chamberlain SH; Masiarz FR; Munemitsu S; Polakis P
    Science; 1993 Dec; 262(5140):1731-4. PubMed ID: 8259518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new Drosophila APC homologue associated with adhesive zones of epithelial cells.
    Yu X; Waltzer L; Bienz M
    Nat Cell Biol; 1999 Jul; 1(3):144-51. PubMed ID: 10559900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The APC gene product and colorectal carcinogenesis.
    Bonneton C; Larue L; Thiéry JP
    C R Acad Sci III; 1996 Oct; 319(10):861-9. PubMed ID: 8977766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of the tumor suppressor adenomatous polyposis coli (APC) by the cyclin-dependent kinase p34.
    Trzepacz C; Lowy AM; Kordich JJ; Groden J
    J Biol Chem; 1997 Aug; 272(35):21681-4. PubMed ID: 9268294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
    Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
    Inukai T; Furuuchi K; Sugita K; Uno K; Ooi A; Sasaki F; Hamada J; Moriuchi T; Nakazawa S
    Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenomatous polyposis coli tumor suppressor protein has signaling activity in Xenopus laevis embryos resulting in the induction of an ectopic dorsoanterior axis.
    Vleminckx K; Wong E; Guger K; Rubinfeld B; Polakis P; Gumbiner BM
    J Cell Biol; 1997 Jan; 136(2):411-20. PubMed ID: 9015311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
    Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
    Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
    Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
    Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.